期刊文献+

吐温-80对p-糖蛋白底物罗丹明123经肠粘膜透过性的影响 被引量:1

Effect of Tween-80 on the permeability of rhodamine 123,a P-gp substrate across rat intestinal membranes in vitro
下载PDF
导出
摘要 目的观察低浓度吐温-80对肠粘膜P-gp的调控作用。方法使用体外扩散池评价罗丹明123(R123)经空肠,回肠和结肠粘膜的经时吸收方向和分泌方向的透过量和透过系数,并测定不同浓度吐温-80对R123和荧光素钠经肠粘膜透过性的影响。R123和荧光素钠在接受室中的浓度用荧光分光光度法测定。结果R123经肠道粘膜的透过性存在部位差,即以空肠、回肠和结肠的次序透过性依次减少。另一方面,R123经肠道分泌方向的透过性显著地高于其吸收方向的透过性。低浓度的吐温-80具有增加R123经吸收方向的透过性。但实验浓度的吐温-80对荧光素钠的肠道转运没有影响。结论低浓度的吐温-80可通过对P-gp功能的抑制而用于改善受P-gp介导药物的吸收,有望提高此类药物的口服生物利用度。 Objective To investigate the effect of Tween-80 in modulating rhodamine123 (R123) permeability across the intestinal membranes. Methods The permeability of R123 or fluorescein sodium (CF) across isolated rat intestinal membranes at the concentration of 5 μg/ml was evaluated using an in vitro diffusion chamber system, in the presence or absence of Tween-80 at different low concentrations. The concentration of R123 or CF in the receptor chamber was determined using fluorospectrophotometry. Results The intestinal membrane permeability of R123 gradually decreased from the jejunum to the ileum and then to the colon. The serosal-to-mucosal transport of R123 was much greater than its mucosal-to-serosal transport. In the presence of low concentrations of Tween-80, the absorptive transport of R123 was significantly increased while its secretory transport decreased depending on the concentration of Tween-80. However, Tween-80 at the experimental concentrations was found to obviously affect the CF transport across the intestinal membranes. Conclusion Low concentrations of Tween-80 may promote the absorption of P-gp-mediated drugs and therefore improve the oral bioavailability of these drugs.
出处 《南方医科大学学报》 CAS CSCD 北大核心 2008年第4期579-581,共3页 Journal of Southern Medical University
基金 广东省科技计划项目(2005B30101007)~~
关键词 P-糖蛋白 罗丹明123 荧光素钠 吐温-80 扩散池 透过性 p-glucoprotein rhodamine 123 fluorescein sodium Tween-80 diffusion chamber permeability
  • 相关文献

参考文献9

  • 1Pleban K, Kopp S, Csaszar E, et al. P-glycoprotein substrate binding domains are located at the transmembrane domain interfaces: a combined photoaffinity labeling-protein homology modeling approach [J]. Mol Pharmacol, 2005, 67(2): 365-74.
  • 2Rosenberg MF, Callaghan R, Modok S, et al. Three-dimensional structure of P-glycoprotein: the transmembrane regions adopt an asymmetric configuration in the nucleotide-bound state [J]. J Biol Chem, 2005, 280(4): 2857-62.
  • 3Perloff MD, Von Moltke LL, Marchand JF, et al. Ritonavir induces P-glycoprotein expression, multidrug resistance-associated protein (MRPI) expression, and drug transporter-mediated activity in a human intestinal cell line [J]. J Pharm Sci, 2001, 90(11): 1829-37.
  • 4Krishna R, Mayer LD. Multidrug resistance (mdr) in cancer mechanisms, reversal using modulators ofmdr and the role ofmdr in influencing the pharmacokinetics ofanticancer drugs [J]. J Eru Pharm Sci, 2000, 11(4): 265-83.
  • 5Zhang Y, Benet LZ. The gut as a barrier to drug absorption: combined role of cytochrome P4503A and P-glycoprotein [J ]. Clin Pharmacokinet, 2001, 40(3): 159-162.
  • 6Comaire G. Impact of exeipients on the absorption of P-glyeoprotein substrates in vitro and in vivo[J ]. Int J Pharm, 2004, 278(1): 119-31.
  • 7Salphati L and Benet LZ. Metabolism of digoxin and digoxigenin digitoxosides in rat liver mierosomes: involvement of eytoehrome P4503A [J]. Xenobiotiea, 1999, 29(2): 171-85.
  • 8Stephens RH, Tanianis-Hughes J, Higgs NB, et al. Regiondependent modulation of intestinal permeability by drug efflux transporters: in vitro studies in mdrla mouse intestine [J]. J Pharmacol Exp Ther, 2002, 303(3): 1095-1101.
  • 9Mouly S, Paine MF. P-glycoprotein increases from proximal to distal regions of human small intestine [J ]. Pharm Res, 2003, 20 (10): 1595-9.

同被引文献29

  • 1黄建耿,斯陆勤,左克源,吴祥根,裘军,李高.普朗尼克抑制P-糖蛋白药泵的作用[J].药学学报,2007,42(9):989-994. 被引量:7
  • 2Lin Y, Shen Q, Katsumi H, et al. Effects of Labrasol and other pharmaceutical excipients on the intestinal transport and absorption of rhodamine 123, a P-glycoprotein substrate, in rats [J]. BiolPharm Bull, 2007, 30(7): 1301-1307.
  • 3Li M, Si L, Pan H, et al. Excipients enhance intestinal absorption of ganciclovir by P-gp inhibition: assessed in vitro by everted gut sac and in situ by improved intestinal perfusion [J]. IntJPharm, 2011, 403 (1-2): 37-45.
  • 4Yang K, Wu J, Li X. Recent advances in the research of P-glycoprotein inhibitors [J]. Biosei Trends, 2008, 2 (4) : 137-146.
  • 5Werle M. Natural and synthetic polymers as inhibitors of drug efflux pumps [J].Pharm Res, 2008, 25 (3) : 500-511.
  • 6Greer DA, Ivey S. Distinct N-glycan glycosylation of P-glycoprotein isolated from the human uterine sarcoma cell line MES-SA/Dx5 [J]. Biochim Biophys Acta, 2007, 1770 (9) : 1275-1282.
  • 7Bansal T, Akhtar N, Jaggi M, et al. Novel formulation approaches for optimising delivery of anticancer drugs based on P-glycoprotein modulation [J]. Drug Diseov Today, 2009, 14 (21-22) : 1067-1074.
  • 8Kim RB. Transporters and drug discovery: why, when, and how [J].Mol Pharm, 2006, 3 (1) : 26-32.
  • 9Shono Y, Nishihara H, Matsuda Y, et al. Modulation of intestinal P-glycoprotein function by cremophor EL and other surfactants by an in vitro diffusion chamber method using the isolated rat intestinal membranes [J]. JPharm Sci, 2004, 93 (4) : 877-885.
  • 10Katneni K, Charman SA, Porter CJ. Impact of Cremophor- EL and polysorbate-80 on digoxin permeability across rat jejunum: delineation of thermodynamic and transporter re-lated events using the reciprocal permeability approach [J]. JPharm Sci, 2007, 96 (2): 280-293.

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部